JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 459,300 shares, a drop of 9.0% from the December 15th total of 505,000 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

JCR Pharmaceuticals Price Performance

Shares of OTCMKTS:JCRRF opened at $4.57 on Monday. The business’s 50-day moving average is $4.57 and its 200-day moving average is $4.58. JCR Pharmaceuticals has a 1 year low of $4.30 and a 1 year high of $4.70.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.